Muchiri RN - Search Results

1

Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.

van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG. van Breemen RB, et al. Among authors: muchiri rn. J Nat Prod. 2022 Jan 28;85(1):176-184. doi: 10.1021/acs.jnatprod.1c00946. Epub 2022 Jan 10. J Nat Prod. 2022. PMID: 35007072 Free PMC article.

2

Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.

Muchiri RN, Kibitel J, Redick MA, van Breemen RB. Muchiri RN, et al. J Am Soc Mass Spectrom. 2022 Jan 5;33(1):181-188. doi: 10.1021/jasms.1c00318. Epub 2021 Dec 23. J Am Soc Mass Spectrom. 2022. PMID: 34939787 Free PMC article.

3

Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds.

van Breemen RB, Muchiri RN. van Breemen RB, et al. Among authors: muchiri rn. Mass Spectrom Rev. 2022 Aug 5:e21800. doi: 10.1002/mas.21800. Online ahead of print. Mass Spectrom Rev. 2022. PMID: 35929396 Free PMC article. Review.

4

Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products.

Muchiri RN, van Breemen RB. Muchiri RN, et al. J Mass Spectrom. 2021;56(5):e4647. doi: 10.1002/jms.4647. Epub 2020 Sep 21. J Mass Spectrom. 2021. PMID: 32955158 Review.

5

Single-Laboratory Validation of UHPLC-MS/MS Assays for Red Clover Isoflavones in Human Serum and Dietary Supplements.

Muchiri RN, van Breemen RB. Muchiri RN, et al. J AOAC Int. 2020 Jul 1;103(4):1160-1166. doi: 10.1093/jaoacint/qsaa033. J AOAC Int. 2020. PMID: 33241325 Free PMC article.

6

Single Laboratory Validation of UHPLC-MS/MS Assays for Six Milk Thistle Flavonolignans in Human Serum.

Muchiri RN, van Breemen RB. Muchiri RN, et al. J AOAC Int. 2021 Mar 5;104(1):232-238. doi: 10.1093/jaoacint/qsaa110. J AOAC Int. 2021. PMID: 33251548 Free PMC article.

7

Drug discovery from natural products using affinity selection-mass spectrometry.

Muchiri RN, van Breemen RB. Muchiri RN, et al. Drug Discov Today Technol. 2021 Dec;40:59-63. doi: 10.1016/j.ddtec.2021.10.005. Epub 2021 Oct 21. Drug Discov Today Technol. 2021. PMID: 34916024 Free PMC article. Review.

8

Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.

Muchiri RN, Kowal KE, Hensley K, Feinstein DL, van Breemen RB. Muchiri RN, et al. Rapid Commun Mass Spectrom. 2018 Nov 30;32(22):1941-1948. doi: 10.1002/rcm.8263. Rapid Commun Mass Spectrom. 2018. PMID: 30117207

9

Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.

Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, Lokken RP, Gaba RC. Elkhadragy L, et al. Among authors: muchiri rn. J Vasc Interv Radiol. 2022 Oct;33(10):1213-1221.e5. doi: 10.1016/j.jvir.2022.07.011. Epub 2022 Jul 16. J Vasc Interv Radiol. 2022. PMID: 35850455

10

Conventional versus drug-eluting embolic transarterial chemoembolization with doxorubicin: comparative drug delivery, pharmacokinetics, and treatment response in a rabbit VX2 tumor model.

Gaba RC, Khabbaz RC, Muchiri RN, Morrison JD, Elkhadragy L, Totura WM, Samuelson JP, Whiteley HE, Deaton RL, Nguyen PL, Sverdlov M, Johnson JJ, van Breemen RB, Lokken RP. Gaba RC, et al. Among authors: muchiri rn. Drug Deliv Transl Res. 2022 May;12(5):1105-1117. doi: 10.1007/s13346-021-00985-8. Epub 2021 Apr 16. Drug Deliv Transl Res. 2022. PMID: 33861419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page